COVID-19: Cedars-Sinai physician co-authors analysis of antiviral drug
A study analyzing patients treated with remdesivir found clinical improvement in 68% of hospitalized COVID-19 patients. The experimental therapy also showed potential in reducing the need for mechanical ventilators and hospital discharge.